|
Market Closed -
Nasdaq
04:00:00 2026-08-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 21.46 USD | +9.77% |
|
+6.19% | - |
| Aug. 14 | Attovia Therapeutics Insider Bought Shares Worth $10,285,000, According to a Recent SEC Filing | MT |
| Aug. 05 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to NASDAQ Composite Index | CI |
| 1 day | +9.77% | ||
| 1 week | -3.07% |
| 1 week | 18.85 | 21.96 | |
| 1 month | 16.15 | 24.32 | |
| Current year | 16.15 | 24.32 | |
| 1 year | 16.15 | 24.32 | |
| 3 years | 16.15 | 24.32 | |
| 5 years | 16.15 | 24.32 | |
| 10 years | 16.15 | 24.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-12-15 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 2023-05-31 |
Tao Fu
CEO | Chief Executive Officer | 54 | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 2023-05-31 |
Tao Fu
BRD | Director/Board Member | 54 | 2023-03-31 |
James Topper
CHM | Chairman | 64 | 2023-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/6/26 | Conversion | 1,865,710 | 4.3359% | |||
| 8/6/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% | |
| 8/6/26 | Frazier Life Sciences Management LP
| Conversion | Company | 57,086,820 | 132.6705% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9.77% | -3.07% | - | - | 841M | ||
| +3.31% | -3.70% | +61.03% | +103.64% | 70.42B | ||
| +1.09% | +3.40% | +51.59% | +93.39% | 65.4B | ||
| -1.03% | -1.52% | +6.31% | -5.28% | 28.28B | ||
| -0.49% | +5.43% | +54.81% | +13.87% | 26.57B | ||
| -2.41% | -7.09% | -8.16% | +455.82% | 27.16B | ||
| +0.37% | +0.70% | +37.37% | -15.78% | 20.09B | ||
| +1.02% | +6.43% | +269.42% | +420.34% | 20.61B | ||
| +0.77% | +0.19% | +8.01% | +520.34% | 15.87B | ||
| -1.50% | +1.60% | +44.13% | +151.30% | 13.9B | ||
| Average | +1.45% | -0.13% | +58.28% | +193.07% | 28.91B | |
| Weighted average by Cap. | +1.13% | +0.68% | +55.95% | +155.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.35 1.16 1.09 0.99 1.87 128.97 1.88 12.84 5.02 65.01 5.07 4.96 215.13 |
| Net income | -39.8M -34.16M -32M -29.27M -55.12M -3.8B -55.33M -379M -148M -1.92B -149M -146M -6.34B | -60.63M -52.03M -48.74M -44.59M -83.96M -5.79B -84.28M -577M -225M -2.92B -228M -223M -9.66B |
| Net Debt | - | - |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | $21.46 | +9.77% | 137,305 |
| 26-08-26 | $19.55 | +1.24% | 143,299 |
| 26-08-25 | $19.31 | -6.35% | 189,293 |
| 26-08-24 | $20.62 | -0.87% | 81,036 |
| 26-08-21 | $20.80 | +2.92% | 362,171 |
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
















